RESUMEN
In rats that were fasted for 2 to 3 days there was a decline in hypothalamic, but not pituitary, beta-endorphin. There was no change in pituitary or hypothalamic adrenocorticotropin content as a result of fasting. Endogenous opiates may be involved in physiological adaptation to fasting.
Asunto(s)
Endorfinas/metabolismo , Ayuno , Hipotálamo/metabolismo , Hormona Adrenocorticotrópica/metabolismo , Animales , Masculino , Hipófisis/metabolismo , Ratas , Factores de TiempoRESUMEN
A method for the in vitro identification of transformed rat liver epithelial and hepatoma cells was developed using the preferential microagglutination of concanavalin A (Con A) coupled to agarose beads (Con A:agarose) to their colonies. Con A:agarose attaches to the cell surface through a specific interaction of the Con A moiety and its receptors. The attachment is dependent on the mobility and aggregation of the Con A: receptor complex on the membrane. Agents which interfere with the interaction reduced the bead density over the colonies. For the quantitative determination of transformed colonies in a mixed-cell population, also containing untransformed cells, it is essential to compare colonies of a similar size or to use the bead density per unit area as the index. When a variety of rat liver epithelial cell lines were tested, the assay proved to be simple, reproducible, and precise. It was found that the increased attachment of Con A:agarose to cell colonies is a characteristic of transformed or malignant rat liver cells.
Asunto(s)
Concanavalina A/metabolismo , Neoplasias Hepáticas Experimentales/metabolismo , Hígado/metabolismo , Animales , Transformación Celular Neoplásica , Células Cultivadas , Regeneración Hepática , Ratas , SefarosaRESUMEN
Ovine trophoblast protein-1 (oTP-1) is the alpha-interferon (IFN alpha) variant, secreted by conceptuses and referred to as type I trophoblast interferon, that is responsible for maternal recognition of pregnancy in sheep. We have previously shown that oTP-1 is as potent an antiviral agent as any known IFN. IFNs also possess anticellular activity and are, in fact, used in cancer therapy and have been found to be effective in the treatment of cancer such as myelogenous and hairy cell leukemias. A significant problem with the currently used IFNs is the undesirable side effect of toxicity at high concentrations. In this study, we examined the anticellular activity and toxicity of oTP-1. It inhibited proliferation but did not exhibit toxicity at high concentrations, unlike known IFN alpha S. In an anticellular assay using colony formation of both the human amnionic line, WISH, and the bovine epithelial line, MDBK, oTP-1 inhibited both colony size and number. oTP-1 was as effective as human and bovine IFN alpha s on human and bovine cells, respectively; thus, it displays potent cross-species activity. Its activity was dose dependent, and inhibition of proliferation could be observed at concentrations as low as 1 unit/ml. Concentrations as high as 50,000 units/ml stopped proliferation, while viability was not impaired. Cell cycle analysis revealed an increased proportion of cells in S phase and a corresponding decreased proportion of cells in G2/M after 48 h of oTP-1 treatment. Therefore, oTP-1 appears to inhibit progress of cells through S phase. oTP-1 antiproliferative effects can be observed as early as 12 h after after the initiation of culture and are maintained through 6 days. Thus, oTP-1 exhibits potent anticellular activity without toxicity across species and may have therapeutic potential as an antitumor agent without the toxic effects generally associated with IFNs.
Asunto(s)
Ciclo Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Interferón Tipo I , Proteínas Gestacionales/farmacología , Animales , Bovinos , Supervivencia Celular/efectos de los fármacos , Ensayo de Unidades Formadoras de Colonias , Reacciones Cruzadas , Relación Dosis-Respuesta a Droga , Humanos , Interferón-alfa/farmacología , Luteolíticos/antagonistas & inhibidoresRESUMEN
In order to study interferon regulatory factor (IRF) family mediation of cell growth regulation, we established U937 cell lines stably transfected with a truncated form of IRF-2 lacking the transcriptional repressor domain. The truncated IRF-2 contained the DNA binding domain (DBD) and bound the ISRE. Phenotypically, the IRF-2 DBD transfectants exhibited reduced cell growth, altered morphology and increased cell death. Consistent with alterations in growth characteristics, the IRF-2 DBD transfectants constitutively expressed higher levels of the cyclin dependent kinase inhibitor p21WAF1/Cip1 than did control clones. The level of p21WAF1/Cip1 expression was positively correlated with the level of DBD expressed, as well as with the level of growth inhibition in these clones. DBD expression also correlated with expression of other members of the growth regulatory complex, cyclin dependent kinase 2 and cyclin A, but not proliferating cell nuclear antigen. These results imply active repression by IRF-2 to keep p21WAF1/Cip1 transcriptionally silent.
Asunto(s)
Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Regulación Neoplásica de la Expresión Génica , Mutación , Proteínas Represoras , Factores de Transcripción , Sitios de Unión/genética , División Celular/genética , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Ciclinas/biosíntesis , Ciclinas/genética , Genes Dominantes , Humanos , Factor 2 Regulador del Interferón , Interferones/genética , Interferones/metabolismo , Elementos de Respuesta , Transfección , Células U937RESUMEN
Interferon (IFN)-induced modulation of two distinct types of Fc receptors (FcR) on bovine bone marrow culture-derived macrophages was quantified by flow cytometry. We have established the presence of separate FcR for monomeric and aggregated IgG on these cells, equivalent to the FcRI and FcRII of mice, respectively. These two kinds of FcR differed in protease sensitivity, hierarchy of preferential binding of immunoglobulin sub-class, and cross-inhibition. Treatment of macrophages with either recombinant bovine IFN-gamma (rBoIFN gamma) or rBoIFN alpha I1 produced a dose-dependent increase in the expression of both types of FcR; however, expression of the FcR for aggregated IgG was increased a full 24 h prior to that for monomeric antibody. Further, expression of the FcRII-equivalent declined substantially by 48 h of IFN exposure, while the presence of the FcRI-equivalent receptor was still enhanced. Finally, low doses (1 unit/ml) of either rBoIFN gamma or rBoIFN alpha I1 failed to alter FcR expression, yet mixtures of IFNs at this concentration were able to potentiate FcR expression. This is the first time that a differential time course of induction of FcR types by IFNs and the effects of mixtures of IFNs on FcR expression has been described in any species.
Asunto(s)
Interferón Tipo I/farmacología , Interferón gamma/farmacología , Macrófagos/inmunología , Receptores Fc/efectos de los fármacos , Animales , Bovinos , Relación Dosis-Respuesta a Droga , Fluoresceína-5-Isotiocianato , Fluoresceínas , Inmunoglobulina G/metabolismo , Macrófagos/efectos de los fármacos , Péptido Hidrolasas/farmacología , Receptores Fc/metabolismo , Proteínas Recombinantes , TiocianatosRESUMEN
Prostaglandin E2 (PGE2) regulates production of a wide array of cytokines. We have found that PGE2 can upregulate the levels of both interleukin-10 (IL-10) and IL-6 produced by activated murine macrophages, but the molecular pathways leading to their augmentation differ. Synthesis of IL-10 in response to PGE2 is dependent on p38 MAP kinase activity, whereas synthesis of IL-6 is not. Evidence to support this derives from two experimental approaches. First, we established that PGE2 is effective in elevating IL-10 levels only when it is added to cells in which p38 kinase has been activated. In contrast, PGE2 can augment IL-6 levels regardless of whether or not p38 kinase is active. Second, we showed that inhibitors that are selective for p38 kinase prevent the IL-10 response to PGE2 but not the IL-6 response. We found that p38 kinase inhibitors are able to inhibit IL-6 production in activated macrophages, but this occurs primarily as a result of their concurrent inhibition of cyclooxygenase-2 and endogenous PGE2 synthesis. These results indicate that macrophage IL-10 and IL-6 expression is differentially regulated by PGE2 and p38 MAP kinase in murine inflammatory macrophages.
Asunto(s)
Dinoprostona/fisiología , Interleucina-10/biosíntesis , Interleucina-6/biosíntesis , Macrófagos/metabolismo , Proteínas Quinasas Activadas por Mitógenos/fisiología , Animales , Femenino , Interleucina-10/metabolismo , Interleucina-6/metabolismo , Activación de Macrófagos , Macrófagos/enzimología , Macrófagos/inmunología , Ratones , Ratones Endogámicos BALB C , Factores de Tiempo , Proteínas Quinasas p38 Activadas por MitógenosRESUMEN
A radioimmunoassay has been developed for quantitation of ovine trophoblast protein-1 (oTP-1), a sheep conceptus secretory protein which allows for maintenance of the corpus luteum during early pregnancy. The assay was validated for dialysed and undialysed culture medium and pregnant uterine flushings ranging from no dilution (neat) to dilutions of 1:2500 for dialysed media, 1:100-1:1000 for undialysed media and 1:50-1:1000 for pregnant uterine flushings. The assay accurately measured oTP-1 added to undiluted and diluted dialysed and undialysed culture media and pregnant uterine flushings. No cross-reaction was detectable for bovine alpha or gamma interferon, bovine calmodulin, feline conceptus secretory proteins, equine conceptus secretory proteins, porcine conceptus secretory proteins, bovine conceptus secretory proteins and proteins in a uterine flushing collected from a non-pregnant ewe. Immunoreactivity in the assay matched that for oTP-1 throughout oTP-1 purification. This assay is the first validated assay which may be used to quantitate production of oTP-1 in culture or content of oTP-1 in uterine flushings.
Asunto(s)
Interferón Tipo I , Proteínas Gestacionales/análisis , Preñez/metabolismo , Radioinmunoensayo/métodos , Animales , Femenino , Luteolíticos/antagonistas & inhibidores , Embarazo , OvinosRESUMEN
The role of the interferon regulatory factory (IRF) family of transcription factors in regulation of interferon alpha and interferon tau antiviral activity was investigated using a dominant negative mutant of IRF-2. The IRF-2 DNA binding domain (DBD), without the C-terminal regulatory region, was stably transfected into myeloid U937 cells. Expression of the IRF-2 DBD resulted in an increase in constitutive 2'5' oligoadenylate synthetase (OAS) levels, indicative of an active repressive mechanism, but was not sufficient to protect cells from challenge with vesicular stomatitis virus. Treatment of the DBD clones with interferons alpha A and tau failed to upregulate 2'5' OAS expression and did not elicit an antiviral response. While interferon alpha A was more sensitive than interferon tau to the inhibitory effects of the IRF-2 DBD, IRF-mediated gene induction is involved in successful interferon alpha and tau-induced anti-VSV activity.
Asunto(s)
Antivirales/farmacología , Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/genética , Interferón Tipo I/farmacología , Interferón-alfa/farmacología , Proteínas Gestacionales/farmacología , Proteínas Represoras , Factores de Transcripción , Virus de la Estomatitis Vesicular Indiana/efectos de los fármacos , 2',5'-Oligoadenilato Sintetasa/metabolismo , Antivirales/metabolismo , Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica , Humanos , Factor 2 Regulador del Interferón , Interferón Tipo I/metabolismo , Interferón-alfa/metabolismo , Mutación , Proteínas Gestacionales/metabolismo , Transducción de Señal , Activación Transcripcional , Transfección , Células U937 , Virus de la Estomatitis Vesicular Indiana/fisiologíaRESUMEN
Macrophages perform important immunoregulatory and host defense functions. Examination of this cell type in the bovine has been restricted because of lack of a means to obtain pure bovine macrophage populations reproducibly. We have developed a system for production of large numbers of macrophages from this species with greater than 99% purity. Stem cells were obtained from the bone marrow of neonatal calves and cultured in vitro in the presence of macrophage-colony-stimulating factor. Bovine bone marrow culture-derived macrophages were esterase-positive, expressed Fc receptors for aggregated IgG, and bovine macrophage differentiation markers. In addition, they displayed class I and class II major histocompatibility (MHC) antigens. The level of MHC antigen expressed could be further enhanced by treatment with recombinant bovine interferons. The macrophages exhibited expected functions, for example, Fc-mediated ingestion of opsonized sheep red blood cells. Augmentation of phagocytic capacity by either alpha or gamma interferon could also be demonstrated. The data reported here confirm that bone marrow culture is a convenient, reliable source of macrophages for investigations of this bovine cell type.
Asunto(s)
Células de la Médula Ósea , Técnicas de Cultivo/métodos , Macrófagos/citología , Animales , Anticuerpos Monoclonales , Antígenos de Diferenciación/biosíntesis , Antígenos de Superficie/biosíntesis , Bovinos , Separación Celular , Factores Estimulantes de Colonias/farmacología , Medios de Cultivo , Citometría de Flujo , Técnica del Anticuerpo Fluorescente , Factor Estimulante de Colonias de Granulocitos y Macrófagos , Sustancias de Crecimiento/farmacología , Antígenos de Histocompatibilidad/biosíntesis , Fagocitosis , Receptores Fc/biosíntesisRESUMEN
Antibody from cattle immunized with purified major surface protein-1 (MSP-1) was demonstrated to significantly enhance phagocytosis of Florida strain Anaplasma marginale by bovine macrophages in vitro. Serum immunoglobulin from individual MSP-1 immunized, protected cattle varied in ability to promote phagocytosis, however all sera were significantly opsonic as compared with sera from sham immunized control cattle.
Asunto(s)
Anaplasma/inmunología , Anticuerpos Antibacterianos/inmunología , Antígenos de Superficie/inmunología , Proteínas Opsoninas/inmunología , Precursores de Proteínas/inmunología , Proteínas Protozoarias/inmunología , Anaplasmosis/inmunología , Animales , Bovinos , Células Cultivadas , Macrófagos/inmunología , Proteína 1 de Superficie de Merozoito , FagocitosisRESUMEN
Interferon tau (IFNtau) produces an array of biological effects, including antiluteolytic, antiviral, antiproliferative and immunomodulatory activities, without the consequent cytotoxicity associated with other type I IFNs. Four anti-IFNtau monoclonal antibodies (MAbs) have been characterized by determining regional epitopes and observation of their effects on IFNtau binding, antiviral and antiproliferative activity. Using an enzyme-linked immunoadsorbent assay (ELISA) developed against six overlapping synthetic peptides representing the entire linear sequence of IFNtau, three antibodies, HL-98, HL-100 and HL-127, were found to react with the carboxy terminal peptide, while HL-129 bound the penultimate amino terminal peptide. Binding studies indicated that MAbs directed against either region could effectively inhibit the binding of alkaline phosphatase labeled IFNtau to cells expressing type I IFN receptors. While only two of the MAbs significantly reversed IFNtau-induced growth inhibition, the antiviral activity of IFNtau was significantly inhibited by MAbs that bound the amino and carboxy termini, confirming the functional importance of these domains in the binding and subsequent activity of IFNtau.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Interferón Tipo I/inmunología , Proteínas Gestacionales/inmunología , Animales , Antivirales/química , Antivirales/inmunología , Bovinos , Línea Celular , Ensayo de Inmunoadsorción Enzimática , Mapeo Epitopo , Humanos , Interferón Tipo I/química , Interferón Tipo I/genética , Fragmentos de Péptidos/química , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/inmunología , Proteínas Gestacionales/química , Proteínas Gestacionales/genética , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunologíaAsunto(s)
Antígenos/inmunología , Enfermedades Transmitidas por los Alimentos/etiología , Choque Séptico/etiología , Linfocitos T Colaboradores-Inductores/inmunología , Síndrome de Inmunodeficiencia Adquirida/etiología , Animales , Antígenos/química , Artritis/etiología , Enterotoxinas/inmunología , Humanos , Ratones , Conformación Proteica , Receptores de Antígenos de Linfocitos T/inmunología , Staphylococcus aureus/patogenicidadRESUMEN
Ia antigen is a receptor for the superantigen staphylococcal enterotoxin A (SEA). Peptides I-A beta b(30-60), I-A beta b(50-70), I-A beta b(65-85), and I-A beta b(80-100) of the MHC class II antigen beta chain on mouse (H-2b) accessory cells were synthesized. Only I-A beta b(65-85) inhibited SEA binding to the mouse B-cell lymphoma line, A20 (H-2d) and the human Burkitt's lymphoma line, Raji (HLA-DR). The I-A beta b(65-85) sequence is a predicted alpha-helix along the hypothetical antigen binding cleft of the Ia molecule. I-A beta b(65-85) also directly and specifically bound both the intact SEA molecule and its Ia binding site, represented by the peptide SEA(1-45). The results suggest that I-A beta b region (65-85) is a necessary site for Ia molecular interaction with the superantigen SEA. Further, the data suggest that the same helical region of other Ia antigens binds SEA irrespective of haplotype and species.
Asunto(s)
Enterotoxinas/farmacología , Antígenos de Histocompatibilidad Clase II/metabolismo , Receptores de Superficie Celular/metabolismo , Secuencia de Aminoácidos , Animales , Sitios de Unión , Fenómenos Químicos , Química , Fluorescencia , Ratones , Modelos Biológicos , Datos de Secuencia Molecular , Conformación Proteica , Receptores de Superficie Celular/efectos de los fármacos , Células Tumorales CultivadasRESUMEN
Staphylococcal enterotoxin A (SEA) binds to class II major histocompatibility complex (MHC) molecules and stimulates monocytes to produce tumor necrosis factor alpha (TNF alpha) and interleukin one (IL-1). We have examined the monocyte stimulatory activity of individual synthetic peptides encompassing the entire sequence of the SEA molecule. Only one peptide, SEA(121-149), induced both TNF alpha and IL-1 production at a concentration as low as 30 microM. Consistent with its effects on monocyte function, SEA(121-149) was shown to bind directly to class II MHC molecules on the surface of both monocytes and B cells, and its binding was inhibited specifically by native SEA. Further, polyclonal antibody to SEA(121-149) inhibited induction of TNF alpha by both SEA and toxic shock syndrome toxin one. Thus, we have identified SEA(121-149) as a peptide agonist of SEA monocyte stimulatory activity.
Asunto(s)
Toxinas Bacterianas , Enterotoxinas/metabolismo , Enterotoxinas/farmacología , Antígenos HLA-D/metabolismo , Interleucina-1/biosíntesis , Monocitos/metabolismo , Fragmentos de Péptidos/farmacología , Superantígenos , Factor de Necrosis Tumoral alfa/biosíntesis , Animales , Anticuerpos/farmacología , Células Cultivadas , Humanos , Células L , Lipopolisacáridos/farmacología , Ratones , Monocitos/efectos de los fármacos , Fragmentos de Péptidos/síntesis química , Staphylococcus aureus , Relación Estructura-Actividad , Células Tumorales CultivadasRESUMEN
The C57Bl/6-derived T cell line, L12-R4, produced murine interferon-gamma (IFN gamma) in response to mitogenic stimulation by phorbol myristate acetate (PMA) or concanavalin A (Con A), but not by staphylococcal enterotoxin A (SEA). Low levels of IFN gamma were produced by SEA stimulation of L12-R4 cells cocultured with C57Bl/6 bone marrow macrophages (BMM). Significantly increased yields of IFN gamma resulted from 48-hour pretreatment of the BMM with recombinant IFN gamma (100 U/ml) prior to coculture. Polyclonal anti-IFN gamma and anti-IFN alpha/beta were used to characterize the interferon as IFN gamma. Paraformaldehyde (0.1%) treatment of IFN gamma-pretreated BMM did not affect IFN gamma production, suggesting that processing of SEA was not required. IFN gamma treatment of BMM resulted in significantly increased expression of immune-associated (Ia) antigen as determined by flow cytometric analysis, suggesting that the accessory cell role of BMM involved Ia antigen. Polyclonal anti-Ia antibody selectively inhibited the production of IFN gamma by SEA-stimulated whole spleen cell cultures, consistent with the necessity of Ia antigen for BMM help in SEA induction of IFN gamma. More interestingly, induction of IFN gamma. These findings suggest that Ia antigen is necessary for BMM accessory function in SEA induction of IFN gamma. More interestingly, the results implicate class II molecules in a positive feedback loop for IFN gamma production by SEA.
Asunto(s)
Enterotoxinas/farmacología , Antígenos de Histocompatibilidad Clase II/fisiología , Interferón gamma/biosíntesis , Macrófagos/fisiología , Linfocitos T/metabolismo , Animales , Células de la Médula Ósea , Línea Celular , Concanavalina A/farmacología , Retroalimentación , Activación de Linfocitos/efectos de los fármacos , Ratones , Staphylococcus , Linfocitos T/efectos de los fármacos , Acetato de Tetradecanoilforbol/farmacologíaRESUMEN
Using the synthetic peptide approach, we have identified a part of the staphylococcal enterotoxin A (SEA) molecule that is responsible for stimulation of T cell proliferation and induction of the lymphokine IFN-gamma. Peptides were synthesized corresponding to amino acids 1 to 27, SEA(1-27), and 28 to 45, SEA(28-45). Both peptides were tested for direct competition with SEA for blockage of SEA induced proliferation and production of IFN-gamma by T cells. Further, antibodies were produced to the peptides and tested for their ability to bind to SEA and block SEA function. SEA (1-27), but not SEA (28-45), blocked proliferation of human peripheral T cells and induction of IFN-gamma by the T cell line, L12-R4. The inhibitory effects were specific, because SEA (1-27) did not inhibit the induction of T cell proliferation by the mitogen PHA. Consistent with the direct inhibition of function, antibodies to SEA (1-27), but not SEA (28-45), neutralized the mitogenic activity of SEA on human PBL. The data suggest that a functional site on SEA that is responsible for its modulation of T cell function involves the N-terminal 27 amino acids. Residues 1 to 27 of SEA could potentially interact at either the level of the TCR or may block the proposed binding of SEA to class II MHC Ag, based on recent data showing that these molecules are involved in SEA-induced proliferation.
Asunto(s)
Antígenos Bacterianos/inmunología , Enterotoxinas/inmunología , Fragmentos de Péptidos/inmunología , Staphylococcus aureus/inmunología , Secuencia de Aminoácidos , Animales , Anticuerpos Antibacterianos/fisiología , Antígenos Bacterianos/análisis , Sitios de Unión de Anticuerpos , Unión Competitiva , Enterotoxinas/análisis , Humanos , Sueros Inmunes/farmacología , Interferón gamma/biosíntesis , Activación de Linfocitos , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Fragmentos de Péptidos/síntesis química , Fragmentos de Péptidos/aislamiento & purificaciónRESUMEN
The superantigen staphylococcal enterotoxin A (SEA) requires interaction with class II major histocompatibility complex (MHC) molecules to activate T cells. We have previously used the synthetic peptide approach to establish one side of the hypothetical class II foreign-antigen binding cleft, alpha-helical region 65-85 of the beta chain, as a binding site involved in accessory cell presentation of SEA to T cells. To further characterize the structural basis for MHC-SEA interaction we have examined the role of the alpha-helical regions of the class II alpha and beta chains in SEA function. Using the synthetic peptide approach, we have found that both alpha-helical regions are required for SEA-induced proliferation. Their corresponding peptides directly bound SEA. Although the beta-chain peptides were able to inhibit SEA binding to human and mouse cells, the alpha-chain peptides were not. The data suggest that the alpha-helices along both sides of the hypothetical class II MHC molecule binding cleft are required for SEA-induced function, whereas the beta-chain alpha-helix is sufficient for SEA binding. A model of superantigen presentation is proposed wherein the MHC beta chain, possibly region 70-80, interacts with SEA region 1-45, whereas another region of SEA binds region 51-80 of the alpha chain.
Asunto(s)
Enterotoxinas/farmacología , Antígenos HLA-D/inmunología , Activación de Linfocitos/efectos de los fármacos , Staphylococcus aureus/inmunología , Linfocitos T/inmunología , Sitios de Unión , Concanavalina A , Replicación del ADN/efectos de los fármacos , Enterotoxinas/inmunología , Citometría de Flujo , Humanos , Técnicas In Vitro , Sustancias Macromoleculares , Modelos Moleculares , Péptidos/síntesis química , Péptidos/inmunología , Unión Proteica , Conformación Proteica , Linfocitos T/efectos de los fármacosRESUMEN
Staphylococcal enterotoxins (SE) are a family of structurally related proteins that are produced by Staphylococcus aureus. They play a role in the pathogenesis of food poisoning and are the most potent activators of T lymphocytes known. The receptors for SE on antigen-presenting cells are major histocompatibility complex class II molecules. Recent studies have shown that a complex of SE and major histocompatibility complex class II molecules is required for binding to the variable region of the T cell antigen receptor beta-chain. SE mitogenic activity is dependent on induction of interleukin 2, which may be intimately involved in the mechanism of SE toxicity. The minor lymphocyte-stimulating "endogenous" self-superantigen has recently been shown to be a retroviral gene product, so that this too is apparently a microbial superantigen. An understanding of the mechanism of action of these microbial superantigens has implications for normal and pathological immune functions.
Asunto(s)
Antígenos Bacterianos/fisiología , Enterotoxinas/fisiología , Staphylococcus aureus/metabolismo , Animales , Antígenos Bacterianos/toxicidad , Enterotoxinas/química , Enterotoxinas/toxicidad , Antígenos de Histocompatibilidad Clase II/fisiología , Humanos , Activación de Linfocitos/efectos de los fármacos , Antígenos Estimulantes de Linfocito Menor/fisiología , Receptores de Antígenos de Linfocitos T/fisiología , Staphylococcus aureus/patogenicidadRESUMEN
Staphylococcal enterotoxins are a family of structurally related proteins that are produced by Staphylococcus aureus. In addition to their role in the pathogenicity of food poisoning, these microbial superantigens have profound effects on the immune system, which makes them useful tools for understanding its mechanism of action. These molecules (24-30 kDa) are highly hydrophilic and exhibit low alpha helix and high beta pleated sheet content, suggesting a flexible, accessible structure. Staphylococcal enterotoxins are among the most potent activators of T lymphocytes known. The receptors for staphylococcal enterotoxins on antigen-presenting cells are major histocompatibility complex (MHC) class II molecules. Further, the alpha-helical regions of the class II molecule are essential for function and appear to interact directly with the NH2-terminal region of staphylococcal enterotoxins such as SEA. Recent studies have shown that a complex of staphylococcal enterotoxin and MHC class II molecules is required for binding to the V beta region of the T cell antigen receptor. Staphylococcal enterotoxin mitogenic activity is dependent on induction of interleukin 2, which may be intimately involved in the mechanism of toxicity. The mouse minor lymphocyte stimulating (M1s) "endogenous" self-superantigen has been shown to be a retroviral gene product, so this too is apparently a microbial superantigen. An understanding of the mechanisms of action of these microbial superantigens has implications for normal and pathological immune functions.